IF

Ingro Finanz AG

Europe, Basel-Landschaft, Switzerland, Bubendorf

Description

Ingro Finanz AG is an investment holding company specialized in late stage venture investments.

Investor Profile

Ingro Finanz AG has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series C rounds (top funding stages).
  • Majority of deals are located in Switzerland, Germany.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Medical.

Stage Focus

  • Series Unknown (50%)
  • Series C (50%)

Country Focus

  • Switzerland (50%)
  • Germany (50%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ingro Finanz AG frequently co-invest with?

LI
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Varuma
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 1
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Landesbank Baden Wurttemberg
Europe, Baden-Wurttemberg, Germany, Stuttgart
Co-Investments: 1
Future Capital
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1
BB
Europe, Solothurn, Switzerland, Wiler
Co-Investments: 1
Co-Investments: 1
Pictet Private Equity Investors S.A.
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1

What are some of recent deals done by Ingro Finanz AG?

NovImmune

Plan-les-ouates, Geneve, Switzerland

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

BiotechnologyMedicalPharmaceutical
Series UnknownMay 12, 2009
Amount Raised: $54,800,000
Ganymed Pharmaceuticals

Mainz, Rheinland-Pfalz, Germany

Ganymed Pharmaceuticals is a biopharmaceutical developing therapeutic drugs designed to kill tumor cells without harming healthy tissues.

BiopharmaBiotechnologyPharmaceutical
Series CSep 24, 2007
Amount Raised: $47,482,979

Find More Investors Like Ingro Finanz AG

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Ingro Finanz AG | Pipeseed